In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.

Hyatt, J M; Nix, D E; Stratton, C W; Schentag, J J

Hyatt, J M; Nix, D E; Stratton, C W; Schentag, J J.

Affiliation

Hyatt JM; Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, New York 14209-1194, USA.

Antimicrob Agents Chemother ; 39(8): 1711-6, 1995 Aug.

Article in En | MEDLINE | ID: mdl-7486906

Subject(s)

Bacteria/drug effects; Drug Therapy, Combination/pharmacology; Anti-Infective Agents/pharmacology; Ciprofloxacin/pharmacology; Enterobacter cloacae/drug effects; Enzyme Inhibitors/pharmacology; Klebsiella pneumoniae/drug effects; Least-Squares Analysis; Microbial Sensitivity Tests; Penicillanic Acid/analogs & derivatives; Penicillanic Acid/pharmacology; Penicillins/pharmacology; Piperacillin/pharmacology; Pseudomonas aeruginosa/drug effects; Staphylococcus aureus/drug effects; Tazobactam; Time Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacteria / Drug Therapy, Combination Type of study: Prognostic_studies Language: En Journal: Antimicrob Agents Chemother Year: 1995 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google